PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
10723089-0	2000	Activation of a rel-A/CEBP-beta-related transcription factor heteromer by PGG-glucan in a murine monocytic cell line.	poly-1-6-glucopyranosyl-1-3-glucopyranose glucan	74-84	v-rel reticuloendotheliosis viral oncogene homolog A (avian)	Mus musculus	16-21	
10723089-0	2000	Activation of a rel-A/CEBP-beta-related transcription factor heteromer by PGG-glucan in a murine monocytic cell line.	poly-1-6-glucopyranosyl-1-3-glucopyranose glucan	74-84	CCAAT/enhancer binding protein (C/EBP), alpha	Mus musculus	22-26	
10723089-3	2000	Previously we reported that PGG-Glucan treatment of mouse BMC2.3 macrophage cells activates a nuclear factor kappa-B-like (NF-kappaB) transcription factor complex containing subunit p65 (rel-A) attached to an unidentified cohort.	poly-1-6-glucopyranosyl-1-3-glucopyranose glucan	28-38	bone mineral content 2	Mus musculus	58-62	
10723089-3	2000	Previously we reported that PGG-Glucan treatment of mouse BMC2.3 macrophage cells activates a nuclear factor kappa-B-like (NF-kappaB) transcription factor complex containing subunit p65 (rel-A) attached to an unidentified cohort.	poly-1-6-glucopyranosyl-1-3-glucopyranose glucan	28-38	v-rel reticuloendotheliosis viral oncogene homolog A (avian)	Mus musculus	182-185	
10723089-3	2000	Previously we reported that PGG-Glucan treatment of mouse BMC2.3 macrophage cells activates a nuclear factor kappa-B-like (NF-kappaB) transcription factor complex containing subunit p65 (rel-A) attached to an unidentified cohort.	poly-1-6-glucopyranosyl-1-3-glucopyranose glucan	28-38	v-rel reticuloendotheliosis viral oncogene homolog A (avian)	Mus musculus	187-192	
10723089-9	2000	Inhibitor kappa-B-alpha (IkappaB-alpha) is associated with the heteromer; this association decreases after PGG-Glucan treatment.	poly-1-6-glucopyranosyl-1-3-glucopyranose glucan	107-117	nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha	Mus musculus	25-38	
10723089-10	2000	These data are consistent with a model whereby treatment of BMC2.3 cells with PGG-Glucan activates IkappaB-alpha via PKC and/or PTK pathways, permitting translocation of the rel-A/CEBP-beta heteromer complex to the nucleus and increases its DNA-binding affinity.	poly-1-6-glucopyranosyl-1-3-glucopyranose glucan	78-88	bone mineral content 2	Mus musculus	60-64	
10723089-10	2000	These data are consistent with a model whereby treatment of BMC2.3 cells with PGG-Glucan activates IkappaB-alpha via PKC and/or PTK pathways, permitting translocation of the rel-A/CEBP-beta heteromer complex to the nucleus and increases its DNA-binding affinity.	poly-1-6-glucopyranosyl-1-3-glucopyranose glucan	78-88	nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha	Mus musculus	99-112	
10723089-10	2000	These data are consistent with a model whereby treatment of BMC2.3 cells with PGG-Glucan activates IkappaB-alpha via PKC and/or PTK pathways, permitting translocation of the rel-A/CEBP-beta heteromer complex to the nucleus and increases its DNA-binding affinity.	poly-1-6-glucopyranosyl-1-3-glucopyranose glucan	78-88	v-rel reticuloendotheliosis viral oncogene homolog A (avian)	Mus musculus	174-179	
10723089-10	2000	These data are consistent with a model whereby treatment of BMC2.3 cells with PGG-Glucan activates IkappaB-alpha via PKC and/or PTK pathways, permitting translocation of the rel-A/CEBP-beta heteromer complex to the nucleus and increases its DNA-binding affinity.	poly-1-6-glucopyranosyl-1-3-glucopyranose glucan	78-88	CCAAT/enhancer binding protein (C/EBP), alpha	Mus musculus	180-184